Leandro A Alves Avelar

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Oxide Nanoparticles

Drug Administration

Top Venues

Future medicinal chemistry

Journal of biomolecular structure & dynamics

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Aaron Burmeister, Alexa Stephan, Leandro A Alves Avelar, Melanie R Müller, Andrea Seiwert, Stefan Höfmann, Fabian Fischer, Hector Torres-Gomez, Michèle Janine Hoffmann, Guenter Niegisch, Felix Bremmer, Patrick Petzsch, Karl Köhrer, Peter Albers, Thomas Kurz, Margaretha A Skowron, Daniel Nettersheim
Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies. Molecular cancer therapeutics 21 (11) (2022)
Fabian Fischer, Leandro A Alves Avelar, Laoise Murray, Thomas Kurz
Designing HDAC-PROTACs: lessons learned so far. Future medicinal chemistry 14 (3) (2021)
Fabian Fischer, Leandro A Alves Avelar
A short overview of resistance to approved histone deacetylase inhibitors. Future medicinal chemistry 13 (14) (2021)
Leandro A Alves Avelar, Dusan Ruzic, Nemanja Djokovic, Thomas Kurz, Katarina Nikolic
Structure-based design of selective histone deacetylase 6 zinc binding groups. Journal of biomolecular structure & dynamics 38 (11) (2019)